drugset / Trial / NCT02550314

A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18

NCT02550314 ↗

NaSingle-groupOpen-labelTreatment

Summary

To assess the efficacy and safety of the regeneration treatment of tympanic membrane with NPC-18 and FBG-18.

Timeline

Start
2015-03
Primary completion
2016-05
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Trafermin Protein / enzyme biologic — —